Suppr超能文献

囊性纤维化气道黏液高渗导致黏液、病原体和炎症相互作用的恶性循环,从而促进疾病持续存在。

Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence.

机构信息

Marsico Lung Institute/Cystic Fibrosis Research Center.

Department of Pathology and Laboratory Medicine.

出版信息

Am J Respir Cell Mol Biol. 2022 Aug;67(2):253-265. doi: 10.1165/rcmb.2021-0359OC.

Abstract

The dynamics describing the vicious cycle characteristic of cystic fibrosis (CF) lung disease, initiated by stagnant mucus and perpetuated by infection and inflammation, remain unclear. Here we determine the effect of the CF airway milieu, with persistent mucoobstruction, resident pathogens, and inflammation, on the mucin quantity and quality that govern lung disease pathogenesis and progression. The concentrations of MUC5AC and MUC5B were measured and characterized in sputum samples from subjects with CF ( = 44) and healthy subjects ( = 29) with respect to their macromolecular properties, degree of proteolysis, and glycomics diversity. These parameters were related to quantitative microbiome and clinical data. MUC5AC and MUC5B concentrations were elevated, 30- and 8-fold, respectively, in CF as compared with control sputum. Mucin parameters did not correlate with hypertonic saline, inhaled corticosteroids, or antibiotics use. No differences in mucin parameters were detected at baseline versus during exacerbations. Mucin concentrations significantly correlated with the age and sputum human neutrophil elastase activity. Although significantly more proteolytic cleavages were detected in CF mucins, their macromolecular properties (e.g., size and molecular weight) were not significantly different than control mucins, likely reflecting the role of bonds in maintaining multimeric structures. No evidence of giant mucin macromolecule reflecting oxidative stress-induced cross-linking was found. Mucin glycomic analysis revealed significantly more sialylated glycans in CF, and the total abundance of nonsulfated O-glycans correlated with the relative abundance of pathogens. Collectively, the interaction of mucins, pathogens, epithelium, and inflammatory cells promotes proteomic and glycomic changes that reflect a persistent mucoobstructive, infectious, and inflammatory state.

摘要

描述囊性纤维化(CF)肺病特征性恶性循环的动力学机制仍不清楚,该机制由黏液停滞引发,并通过感染和炎症持续存在。在这里,我们确定 CF 气道环境(持续的黏液阻塞、常驻病原体和炎症)对控制肺病发病机制和进展的粘蛋白数量和质量的影响。我们针对其高分子特性、蛋白水解程度和糖组学多样性,测量并分析了 CF 患者(n = 44)和健康对照者(n = 29)的痰样本中 MUC5AC 和 MUC5B 的浓度。这些参数与定量微生物组和临床数据相关。与对照痰相比,CF 中的 MUC5AC 和 MUC5B 浓度分别升高了 30 倍和 8 倍。粘蛋白参数与高渗盐水、吸入性皮质类固醇或抗生素的使用无关。在缓解期与基线相比,没有检测到粘蛋白参数的差异。粘蛋白浓度与年龄和痰中人中性粒细胞弹性蛋白酶活性显著相关。尽管在 CF 粘蛋白中检测到更多的蛋白水解裂解,但它们的高分子特性(如大小和分子量)与对照粘蛋白没有显著差异,这可能反映了键在维持多聚体结构中的作用。没有发现反映氧化应激诱导交联的巨大粘蛋白大分子的证据。粘蛋白糖组学分析显示 CF 中唾液酸化聚糖明显增多,非硫酸化 O-聚糖的总丰度与病原体的相对丰度相关。总之,粘蛋白、病原体、上皮和炎症细胞的相互作用促进了蛋白质组学和糖组学的变化,反映了持续的黏液阻塞、感染和炎症状态。

相似文献

2
MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
Am J Respir Cell Mol Biol. 2004 Jul;31(1):86-91. doi: 10.1165/rcmb.2003-0345OC. Epub 2004 Feb 26.
3
MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Am J Respir Crit Care Med. 2007 Apr 15;175(8):816-21. doi: 10.1164/rccm.200607-1011OC. Epub 2007 Jan 25.
4
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
J Clin Invest. 2014 Jul;124(7):3047-60. doi: 10.1172/JCI73469. Epub 2014 Jun 2.
5
Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis.
J Cyst Fibros. 2022 Nov;21(6):959-966. doi: 10.1016/j.jcf.2022.04.008. Epub 2022 Apr 16.
6
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.
Am J Respir Crit Care Med. 2020 Mar 15;201(6):661-670. doi: 10.1164/rccm.201906-1219OC.
8
IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis.
J Clin Invest. 2019 Oct 1;129(10):4433-4450. doi: 10.1172/JCI125669.
9
Gel-forming mucins form distinct morphologic structures in airways.
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6842-6847. doi: 10.1073/pnas.1703228114. Epub 2017 Jun 12.

引用本文的文献

1
The effect of modulators on lung function following inpatient treatment for CF exacerbations.
Front Pediatr. 2025 Aug 21;13:1654122. doi: 10.3389/fped.2025.1654122. eCollection 2025.
2
Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target.
Eur Respir J. 2025 Sep 17;66(3). doi: 10.1183/13993003.00081-2025. Print 2025 Sep.
3
Sputum quality affects assessment of airway microbiology in childhood asthma.
Respir Res. 2025 Jun 4;26(1):209. doi: 10.1186/s12931-025-03266-x.
4
Macroheterogeneities Induced by Disulfide Bond Reduction in Native Mucus.
ACS Appl Bio Mater. 2025 Jun 16;8(6):4647-4656. doi: 10.1021/acsabm.4c01758. Epub 2025 May 19.
6
Modulation of pulmonary immune functions by the secondary metabolite pyocyanin.
Front Immunol. 2025 Mar 24;16:1550724. doi: 10.3389/fimmu.2025.1550724. eCollection 2025.
7
pharmacokinetic/pharmacodynamic modeling of the effect of mucin on polymyxin B activity against .
Antimicrob Agents Chemother. 2025 May 7;69(5):e0153524. doi: 10.1128/aac.01535-24. Epub 2025 Mar 26.
8
Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery.
Pharmaceuticals (Basel). 2024 Dec 4;17(12):1628. doi: 10.3390/ph17121628.
9
Rheological comparison of sputum and reconstituted airway epithelium mucus.
Sci Rep. 2024 Dec 30;14(1):31660. doi: 10.1038/s41598-024-80932-y.

本文引用的文献

3
Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.
Am J Respir Crit Care Med. 2020 Mar 15;201(6):661-670. doi: 10.1164/rccm.201906-1219OC.
4
Roles of mucus adhesion and cohesion in cough clearance.
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12501-12506. doi: 10.1073/pnas.1811787115. Epub 2018 Nov 12.
6
Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways.
Am J Respir Crit Care Med. 2019 Mar 15;199(6):715-727. doi: 10.1164/rccm.201804-0734OC.
7
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18.
8
Filter-Aided Sample Preparation for Proteome Analysis.
Methods Mol Biol. 2018;1841:3-10. doi: 10.1007/978-1-4939-8695-8_1.
9
An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Am J Respir Crit Care Med. 2019 Jan 15;199(2):171-180. doi: 10.1164/rccm.201802-0245OC.
10
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.
Eur Respir J. 2018 Jul 11;52(1). doi: 10.1183/13993003.00242-2018. Print 2018 Jul.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验